Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Andrews

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Forensic Sciences|November 4, 2016
Evaluation of Cross-contamination of Nylon Bags with Heavy-loaded Gasoline Fire Debris and with Automotive Paint ThinnerFilipa Belchior, Stephen P Andrews
The Journal of Organic Chemistry|July 4, 2003
Convenient preparation and use of a new analytical construct for the analysis and development of solid-phase chemistriesStephen P Andrews, Mark Ladlow
Journal of Medicinal Chemistry|November 5, 2015
Small Molecule CXCR3 AntagonistsStephen P Andrews, Rhona J Cox
Chemical Reviews|June 23, 2016
Structurally Enabled Discovery of Adenosine A<sub>2A</sub> Receptor AntagonistsAli Jazayeri, Stephen P Andrews, Fiona H Marshall
Chemmedchem|December 20, 2013
Structure-based and fragment-based GPCR drug discoveryStephen P Andrews, Giles A Brown, John A Christopher
Combinatorial Chemistry & High Throughput Screening|March 23, 2004
Automated parallel, multi-step polymer-assisted solution phase (PASP) synthesis of substituted benzimidazole derivativesStephen P Andrews, Daniel Jönsson, Brian H Warrington, et al.
Angewandte Chemie (International Ed. in English)|November 8, 2007
Enantioselective preparation of 1,1-diarylethanes: aldehydes as removable steering groups for asymmetric synthesisThomas C Fessard, Stephen P Andrews, Hajime Motoyoshi, et al.
Current Topics in Medicinal Chemistry|September 30, 2015
Orexin Receptor Antagonists: Historical Perspectives and Future OpportunitiesStephen P Andrews, Sarah J Aves, John A Christopher, et al.
Organic & Biomolecular Chemistry|April 28, 2007
Design and total synthesis of unnatural analogues of the sub-nanomolar SERCA inhibitor thapsigarginStephen P Andrews, Malcolm M Tait, Matthew Ball, et al.
Organic Letters|January 30, 2007
Total synthesis of thapsigargin, a potent SERCA pump inhibitorMatthew Ball, Stephen P Andrews, Frank Wierschem, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Forensic Sciences|November 4, 2016
Evaluation of Cross-contamination of Nylon Bags with Heavy-loaded Gasoline Fire Debris and with Automotive Paint ThinnerFilipa Belchior, Stephen P Andrews
The Journal of Organic Chemistry|July 4, 2003
Convenient preparation and use of a new analytical construct for the analysis and development of solid-phase chemistriesStephen P Andrews, Mark Ladlow
Journal of Medicinal Chemistry|November 5, 2015
Small Molecule CXCR3 AntagonistsStephen P Andrews, Rhona J Cox
Chemical Reviews|June 23, 2016
Structurally Enabled Discovery of Adenosine A<sub>2A</sub> Receptor AntagonistsAli Jazayeri, Stephen P Andrews, Fiona H Marshall
Chemmedchem|December 20, 2013
Structure-based and fragment-based GPCR drug discoveryStephen P Andrews, Giles A Brown, John A Christopher
Combinatorial Chemistry & High Throughput Screening|March 23, 2004
Automated parallel, multi-step polymer-assisted solution phase (PASP) synthesis of substituted benzimidazole derivativesStephen P Andrews, Daniel Jönsson, Brian H Warrington, et al.
Angewandte Chemie (International Ed. in English)|November 8, 2007
Enantioselective preparation of 1,1-diarylethanes: aldehydes as removable steering groups for asymmetric synthesisThomas C Fessard, Stephen P Andrews, Hajime Motoyoshi, et al.
Current Topics in Medicinal Chemistry|September 30, 2015
Orexin Receptor Antagonists: Historical Perspectives and Future OpportunitiesStephen P Andrews, Sarah J Aves, John A Christopher, et al.
Organic & Biomolecular Chemistry|April 28, 2007
Design and total synthesis of unnatural analogues of the sub-nanomolar SERCA inhibitor thapsigarginStephen P Andrews, Malcolm M Tait, Matthew Ball, et al.
Organic Letters|January 30, 2007
Total synthesis of thapsigargin, a potent SERCA pump inhibitorMatthew Ball, Stephen P Andrews, Frank Wierschem, et al.
Pageof 3